Petros Pharmaceuticals Inc

General ticker "PTPI" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $3.2M

Petros Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -34.5%.

Estimated limits based on current volatility of 15.9%: low 0.25$, high 0.35$

Factors to consider:

  • US accounted for 80.1% of revenue in the fiscal year ended 2022-12-31
  • Current price 65.2% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.82$, 2.63$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.10$, 3.22$]

Financial Metrics affecting the PTPI estimates:

  • Negative: Non-GAAP EPS, $ of -11.61 <= 0.10
  • Negative: Operating profit margin, % of -70.05 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -71.97 <= 2.35

Similar symbols

Short-term PTPI quotes

Long-term PTPI plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $7.81MM $9.38MM $5.82MM
Operating Expenses $25.86MM $29.30MM $19.44MM
Operating Income $-18.05MM $-19.92MM $-13.62MM
Non-Operating Income $9.06MM $-0.12MM $5.45MM
Interest Expense $0.37MM $0.60MM $0.54MM
R&D Expense $1.79MM $1.74MM $2.41MM
Income(Loss) $-8.99MM $-20.04MM $-8.16MM
Profit(Loss) $-8.99MM $-20.04MM $-8.16MM
Stockholders Equity $35.54MM $16.70MM $12.48MM
Inventory $0.52MM $1.82MM $1.61MM
Assets $67.39MM $32.42MM $33.80MM
Operating Cash Flow $-11.86MM $-12.80MM $-7.63MM
Capital expenditure $0.00MM $0.00MM $0.00MM
Financing Cash Flow $18.57MM $-1.62MM $11.54MM
Earnings Per Share* $-8.59 $-13.06 $-6.35

* EPS are Split Adjusted, recent splits may be reflected with a delay.